In an environment where the regulatory and reimbursement authorities continue to raise the bar for new oncology therapies, how are sponsors adapting clinical trial designs?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Multiparametric bone MRI can improve CT-guided bone biopsy target selection in cancer patients and increase diagnostic yield and feasibility of next-generation tumour sequencing
European Radiology Open Access 29 January 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Regulatory Innovation. BioCentury 39, A1–A28, September 13, 2010.
Jallal, B. Euro. Pharm. Rev. 16, 29–31 (2011).
LaVallee, T. Onc. News. 6, 52 (2011).
Heinemann, V. et al. Cancer Treat. Rev. 35, 262–271 (2009).
Beckman, R.A. et al. Nat. Rev. Drug Discov. 10, 735–748 (2011).
Sikorski, R. & Yao, B. Sci. Transl. Med. 1, 10ps11 (2009).
Barker, A.D. et al. Clin. Pharmacol. Ther. 86, 97–100 (2009).
Fleming, T. & Richardson, B.A. J. Infect. Dis. 190, 666–674 (2004).
Patlak, M., Nass, S.J. & Balogh, E. The National Cancer Policy Summit: Opportunities and Challenges in Cancer Research and Care. http://books.nap.edu/openbook.php?record_id=13101 (The National Academies Press, Washington, DC, 2011).
D'Agostino, R.B. N. Engl. J. Med., 365, e2 (2011).
Chen, K. & Shan, M. Contemp. Clin. Trials 29, 32–41 (2008).
Vickers, A.J., Ballen, V. & Scher, H.I. Clin. Cancer Res. 13, 972–976 (2007).
Thall, P.F. UT MD Anderson Cancer Center Department of Biostatistics Working Paper Series http://biostats.bepress.com/mdandersonbiostat/paper35/ (2007).
Robert, C. et al. N. Engl. J. Med. 364, 2517–2526 (2011).
Maitland, M. et al. J. Clin. Oncol. 29, 3109–3111 (2011).
Hoos, A. et al. J. Natl. Cancer Inst. 102, 1388–1397 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Bradley, E. Incorporating biomarkers into clinical trial designs: points to consider. Nat Biotechnol 30, 596–599 (2012). https://doi.org/10.1038/nbt.2296
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2296
This article is cited by
-
Multiparametric bone MRI can improve CT-guided bone biopsy target selection in cancer patients and increase diagnostic yield and feasibility of next-generation tumour sequencing
European Radiology (2022)
-
Advances in the design of nanomaterial-based electrochemical affinity and enzymatic biosensors for metabolic biomarkers: A review
Microchimica Acta (2018)
-
Drugs’ development in acute heart failure: what went wrong?
Heart Failure Reviews (2018)
-
Creative trial design in RA: optimizing patient outcomes
Nature Reviews Rheumatology (2013)